MERCK & CO., INC.

Calendar Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 01:30:51 20/05/2026 am IST			Pre-market 04:30:10 am
114.24 ^USD	+1.49%		114.08	-0.14%

19/05	Can Nvidia Do It Again?
19/05	Merck to Collaborate With Exelixis on Phase 3 Colorectal Cancer Trial	MT

Chart calendar Merck & Co., Inc.

f989ff2b99af94a.bje7cOO6F0Ws01hssmtyGl0WmHlOr6WMyYYYj_GGhM8.LXOLKoTvcgvnqzpfwzQ2TjlM_0g2luy1lsRT7YKxsahdf-E31vdDFN6rLw~92f8cb85f617cbbc832fef8890219d30

Upcoming events on Merck & Co., Inc.

26/05/2026	Annual General Meeting	Day
26/05/2026	Présentation aux Actionnaires / Analystes	06:30 pm
02/06/2026	Information meeting	04:30 am
04/08/2026	Earnings presentation	06:30 pm
04/08/2026	Earnings release - Q2 2026
29/10/2026	Earnings presentation	06:30 pm
29/10/2026	Earnings release - Q3 2026	Day
02/02/2027	Earnings presentation	07:30 pm
02/02/2027	Earnings release - Q4 2026	Pre-market
29/04/2027	Earnings release - Q1 2027	Pre-market
29/04/2027	Earnings presentation	06:30 pm

Past events on Merck & Co., Inc.

30/04/2026	Earnings presentation	06:30 pm
03/02/2026	Earnings presentation	07:30 pm
10/11/2025	Présentation aux Actionnaires / Analystes	05:31 am
30/10/2025	Earnings presentation	06:30 pm
29/07/2025	Earnings presentation	06:30 pm
17/07/2025	Information meeting	06:30 pm
27/05/2025	Annual General Meeting	Day
27/05/2025	Présentation aux Actionnaires / Analystes	06:30 pm

Past dividends on Merck & Co., Inc.

16/03/2026	Ex-dividend date - 0.85 USD	09:30 am
15/12/2025	Ex-dividend date - 0.85 USD	10:30 am
15/09/2025	Ex-dividend date - 0.81 USD	09:30 am
16/06/2025	Ex-dividend date - 0.81 USD	09:30 am

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	60 115 59 938 0.3%	64 168 63 997 0.27%	65 011 64 779 0.36%	66 848	70 305	75 734
EBITDA Million USD	Released Forecast Spread	10 083 9 362 7.71%	27 897 26 650 4.68%	32 617 29 685 9.88%	16 449	33 831	36 383
EBIT Million USD	Released Forecast Spread	6 211 6 066 2.4%	23 398 23 593 -0.83%	26 779 26 529 0.94%	11 837	28 667	31 758
Earnings before Tax (EBT) Million USD	Released Forecast Spread	1 889 2 857 -33.89%	19 936 21 364 -6.68%	21 067 22 876 -7.91%	6 487	24 720	28 316
Net income Million USD	Released Forecast Spread	365 1 682 -78.3%	17 117 17 500 -2.19%	18 254 19 815 -7.88%	5 556	20 425	23 378
EPS USD	Released Forecast Spread	0,14 0,56 -75.16%	6,74 7,01 -3.82%	7,28 7,74 -5.99%	2,24	8,31	9,60
Announcement Date		01/02/24	04/02/25	03/02/26	-

Quarterly results

Fiscal Period	March	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million USD	Released Forecast Spread	16 657 16 514 0.87%	15 624 15 507 0.76%	15 529 15 331 1.29%	15 806 15 873 -0.42%	17 276 16 978 1.76%	16 400 16 206 1.2%	16 286 15 846 2.77%	16 387	17 549	16 658	16 667	17 465	19 325	18 720
EBITDA Million USD	Released Forecast Spread	5 466 5 999 -8.89%	6 422 7 737 -16.99%	7 722 6 882 12.2%	7 484 7 160 4.52%	8 710 8 313 4.77%	8 702 7 843 10.95%	-1 521	3 606	11 544	12 290	7 107
EBIT Million USD	Released Forecast Spread	4 913 5 046 -2.63%	5 225 5 140 1.66%	6 623 6 533 1.38%	6 365 6 206 2.56%	7 556 7 139 5.84%	6 236 6 134 1.66%	-1 884 -2 478 23.97%	489	7 126	5 798	5 975
Earnings before Tax (EBT) Million USD	Released Forecast Spread	4 090 4 535 -9.82%	4 170 4 641 -10.15%	5 903 5 880 0.4%	4 999 5 672 -11.86%	6 745 6 465 4.32%	3 420 4 751 -28.02%	-3 534 -3 581 1.31%	-826	5 624	4 787
Net income Million USD	Released Forecast Spread	3 157 3 419 -7.66%	3 743 3 700 1.16%	5 079 4 983 1.93%	4 427 4 651 -4.81%	5 785 5 155 12.22%	2 963 4 341 -31.74%	-4 240 -3 910 -8.44%	1 834	4 598	3 904	4 725
EPS USD	Released Forecast Spread	1,24 1,43 -13.39%	1,48 1,49 -0.58%	2,01 1,93 3.97%	1,76 1,84 -4.45%	2,32 2,06 12.85%	1,19 1,68 -29.16%	-1,72 -1,58 -8.63%	0,74	1,86	1,58	1,91
Announcement Date		31/10/24	04/02/25	24/04/25	29/07/25	30/10/25	03/02/26	30/04/26	-	-	-	-	-	-	-

Upcoming sector events for Merck & Co., Inc.

Today	ALNYLAM PHARMACEUTICALS, INC.	Présentation aux Actionnaires / Analystes	08:00 pm
Today	ALNYLAM PHARMACEUTICALS, INC.	Annual General Meeting	08:00 pm
Today	ROIVANT SCIENCES LTD.	Earnings presentation	05:30 pm
Today	ROIVANT SCIENCES LTD.	Earnings release - Q4 2026
Today	MANKIND PHARMA LIMITED	Earnings presentation	12:00 pm
Today	ANTHEM BIOSCIENCES LIMITED	Earnings presentation	11:00 am
Today	HYBIO PHARMACEUTICAL CO., LTD.	Annual General Meeting	01:00 pm
Today	FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.	Annual General Meeting	12:00 pm
Today	GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.	Annual General Meeting	12:15 pm
Today	NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.	Annual General Meeting	11:30 am

Past sector events for Merck & Co., Inc.

Today	DR. REDDY'S LABORATORIES LIMITED	Présentation aux Actionnaires / Analystes	06:30 am
Today	DR. REDDY'S LABORATORIES LIMITED	Présentation aux Actionnaires / Analystes	06:30 am
Today	ERIS LIFESCIENCES LIMITED	Board of Directors Meeting	Day
Today	ONENESS BIOTECH CO., LTD.	Annual General Meeting	06:30 am
19/05/2026	AMGEN INC.	Présentation aux Actionnaires / Analystes	11:30 pm
19/05/2026	AMGEN INC.	Annual General Meeting	11:30 pm
19/05/2026	DAIICHI SANKYO COMPANY, LIMITED	Information meeting	Day
19/05/2026	SICHUAN BIOKIN PHARMACEUTICAL CO.,LTD.	Annual General Meeting	12:00 pm
19/05/2026	DR. REDDY'S LABORATORIES LIMITED	Présentation aux Actionnaires / Analystes	06:00 am
19/05/2026	MANKIND PHARMA LIMITED	Earnings release - Q4 2026

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

Stock Market
Equities
MRK Stock
Calendar Merck & Co., Inc.

As early as today, start finding the best investment opportunities!